| Literature DB >> 35919852 |
Gerardo Uriel Bautista-Trujillo1, Mayra Isabel Hernández-Hernández2, Javier Gutiérrez-Jiménez3, Fernando Azpiri-Álvarez1, Rene Pinto-Ruiz2, Francisco Guevara-Hernández2, Benigno Ruiz-Sesma1, Paula Mendoza-Nazar1, Daniel González-Mendoza4.
Abstract
Piglets suffer from diarrhea caused by the Shiga toxin-producing Escherichia coli (STEC) and can be carriers of the bacteria, with public health consequences in developing countries. The aim of the present study was to study the prevalence of STEC O157 in feces of 465 piglets and 54 food mixes from backyard systems, the antimicrobial susceptibility of STEC and the frequency of genes encoding extended-spectrum β-lactamases. The E. coli was isolated from 75.90 % of the evaluated feces. The STEC strains were identified in 33.11% of the sampled population and in 43.60% of the piglets carrying E. coli. Among STEC strains, the stx1 gene was the most frequent (22.30%). The rfbO157 gene was amplified in 47.40% of the STEC strains. High frequencies of STEC strains were not susceptible to ampicillin, carbenicillin and tetracycline. The blaTEM gene (52) was the most frequent among strains not susceptible to ampicillin. Class 1 integrons were the most frequent in those strains. Of the identified STEC strains, 48.70% were considered as multi-drug resistant and 1.90% were considered extensively drug resistant. In the supplied food, STEC O157 strains were identified in 25.00% of the STEC strains. We conclude that the piglets from backyard systems are carriers of STEC O157 strains not susceptible to common antibiotics, including penicillins and tetracyclines. In addition, supplied food is a source of this type of pathogenic bacteria. Through their direct contact with humans, the piglets and food represent a potential source of bacterial dissemination capable of producing gastrointestinal infections in humans.Entities:
Keywords: Antimicrobial susceptibility; Carrier; Diarreagenic Escherichia coli; Prevalence; Zoonosis
Year: 2022 PMID: 35919852 PMCID: PMC9340280 DOI: 10.30466/vrf.2020.128661.2977
Source DB: PubMed Journal: Vet Res Forum ISSN: 2008-8140 Impact factor: 0.950
Primers used in this study
|
|
|
|
|
|
|---|---|---|---|---|
|
| F: AAAACGGCAAGAAAAAGCAG | β-glucuronidase | 147 | |
| R: ACGCGTGGTTAACAGTCTTGCG | ||||
|
| F: CTGGATTTAATGTCGCATAGTG | Shiga toxin 1 | 150 | |
| R: AGAACGCCCACTGAGATCATC | ||||
|
| F: GGCACTGTCTGAAACTGCTCC | Shiga toxin 2 | 255 | |
| R: TCGCCAGTTATCTGACATTCTG | ||||
|
| F: CGGACATCCATGTGATATGG | Specific O-polysaccharide | 259 | |
| TTGCCTATGTACAGCTAATCC | ||||
|
| F: ATAAAATTCTTGAAGACGAAA | beta-lactamase TEM | 1080 | |
| R: GACAGTTACCAATGCTTAATC | ||||
|
| F: TTATCTCCCTGTTAGCCACC | beta-lactamase SHV | 795 | |
| R: GATTTGCTGATTTCGCTCGG | ||||
|
| F: CGCTTTGCGATGTGCAG | beta-lactamase SHV | 550 | |
| R: ACCGCGATATCGTTGGT | ||||
|
| F: TCAACTTTCAAGATCGCA | beta-lactamase OXA | 591 | |
| R: GTGTGTTTAGAATGGTGA | ||||
|
| F: GACAGCCTCTTTCTCCACA | beta-lactamase CMY | 1000 | |
| R: TGG AACGAAGGCTACGTA | ||||
|
| F: GGGTCAAGGATCTGGATTTCG |
| 483 | |
| R: ACATGCGTGTAAATCATCGTCG | ||||
|
| F: CGGGATCCCGGACGGCATGCACGATTTGTA | class 2 integron | variable | |
| R: GATGCCATCGCAAGTACGAG |
Antimicrobial non-susceptibility profile of the Shiga toxin-producing Escherichia coli (STEC) strains
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| 81.10 (125) | 89.80 (71) | 83.30 (20) | 66.60 (34) | 91.70 (67) |
|
| 25.30 (39) | 26.50 (21) | 20.80 (5) | 25.50 (13) | 43.80 (32) |
|
| 66.80 (103) | 67.10 (53) | 70.80 (17) | 64.70 (33) | 82.10 (60) |
|
| 5.80 (9) | 3.80 (3) | 8.30 (2) | 7.80 (4) | 10.90 (8) |
|
| 20.70 (32) | 17.70 (14) | 25.00 (6) | 23.50 (12) | 36.90 (27) |
|
| 15.60 (24) | 12.60 (10) | 20.80 (5) | 17.60 (9) | 28.70 (21) |
|
| 11.70 (18) | 11.40 (9) | 16.70 (4) | 9.80 (5) | 19.10 (14) |
|
| 26.60 (41) | 25.30 (20) | 33.30 (8) | 25.50 (13) | 42.40 (31) |
|
| 11.00 (17) | 11.40 (9) | 12.50 (3) | 9.80 (5) | 23.20 (17) |
|
| 11.70 (18) | 11.40 (9) | 16.70 (4) | 9.80 (5) | 21.90 (16) |
|
| 14.90 (24) | 16.40 (13) | 25.00 (6) | 9.80 (5) | 30.40 (22) |
|
| 27.90 (43) | 32.90 (26) | 20.80 (5) | 23.50 (12) | 34.20 (25) |
|
| 21.40 (33) | 25.30 (20) | 29.00 (7) | 11.70 (6) | 35.60 (26) |
|
| 8.40 (12) | 10.30 (8) | 8.30 (2) | 3.90 (2) | 12.30 (9) |
|
| 48.00 (74) | 43.00 (34) | 62.50 (15) | 49.00 (25) | 83.50 (61) |
Genes of extended spectrum β-lactamase producing Shiga toxin-producing Escherichia coli (STEC) strains isolated from piglets
|
|
|
|
|
|---|---|---|---|
|
| 71 |
| 32 |
|
| 20 |
| 5 |
|
| 51 |
| 15 |
Non susceptible profiles in STEC strains isolates from piglets
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| (0) | 0 | 4 | ||||||||
| (1) | AMP | 9 | TEM (4), CTX (5) | |||||||
| (1) | CAR | 1 | ||||||||
| (1) | AMP CAR | 13 | TEM (7), CTX (6) | |||||||
| (2) | AMP STX | 1 | Class 1 | |||||||
| (2) | AMP CEF | 1 | ||||||||
| (2) | AMP CHL | 1 | ||||||||
| (2) | AMP NIT | 1 | ||||||||
| (2) | AMP CAR CEF | 2 | TEM | Class 1 | ||||||
| (2) | AMP AMK CAR | 2 | TEM | Class 1 | ||||||
| MDR (3) | AMP STX TET | 1 | CTX | Class 1 | O157 | |||||
| (2) | AMP CAR TET | 1 | TEM | Class 1 | ||||||
| MDR (3) | CHL STX TET | 1 | Class 1 | O157 | ||||||
| (2) | AMP CAR CHL | 3 | TEM (3) | |||||||
| MDR (3) | AMP CHL TET | 1 | TEM | Class 1 | ||||||
| MDR (3) | AMP CAR CHL TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | CAR CEF CTX NOR | 1 | O157 | |||||||
| MDR (3) | AMP AMC CHL TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP CAR STX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CHL TET | 2 | SHV (1) | Class 1 | ||||||
| MDR (4) | CAR CEF CHL TET | 1 | Class 1 | O157 | ||||||
| (2) | AMP AMC CAR CEF | 1 | TEM | O157 | ||||||
| MDR (3) | AMP AMK CEF CTX | 1 | TEM | O157 | ||||||
| MDR (4) | AMP CHL STX TET | 1 | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CTX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP AMC CAR STX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP AMC AMK CAR TET | 1 | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CEF CTX NET | 1 | SHV | O157 | ||||||
| MDR (4) | AMP AMK CEF STX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (5) | AMP CAR NOR CHL STX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP AMC CAR CIP NOR TET | 1 | CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC AMK CEF STX TET | 1 | SHV | Class 1 | O157 | |||||
| MDR (4) | AMP AMC CAR CEF CHL STX | 1 | TEM | Class 1 | ||||||
| MDR (4) | AMP AMK CAR GEN NET CTX TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR AMK GEN CIP NOR | 1 | CTX | O157 | ||||||
| MDR (5) | AMP AMC CAR AMK GEN CEF NET | 1 | TEM | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR CHL STX NIT TET | 3 | TEM+CTX+ SHV | Class 1 | ||||||
| MDR (5) | AMP AMC CAR OXA CEF CHL STX TET | 1 | TEM+CTX | Class 1 | ||||||
| MDR (6) | AMP NET CTX CIP NOR CHL TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR AMK GEN CEF CHL TET | 1 | CTX | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR CEF CHL STX NIT TET | 1 | TEM | Class 1 | O157 | |||||
| MDR (7) | AMP CAR GEN CEF CIP NOR STX NIT TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP CAR GEN NET CEF CTX CIP NOR TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR AMK CIP NOR CHL NIT TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR AMK GEN NET CEF NOR TET | 1 | TEM+CTX+SHV | Class 1 | O157 | |||||
| MDR (7) | AMP AMC CAR AMK NET NOR CHL STX NIT TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (7) | AMP AMC CAR OXA GEN NET CIP NOR CHL STX TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (7) | AMP AMC CAR OXA AMK GEN CEF CTX CIP NOR CHL STX TET | 1 | TEM+CTX | Class 1 | O157 | |||||
| MDR (7) | AMP AMC CAR GEN NET CEF CTX CIP NOR CHL STX TET | 1 | TEM+CTX+SHV | Class 1 | O157 | |||||
|
| ||||||||||
| (0) | 0 | (2) | ||||||||
| (1) | AMP | (4) | ||||||||
| (1) | AMP CAR | (1) | ||||||||
| MDR (3) | CAR CHL TET | (1) | Class 1 | O157 | ||||||
| (2) | AMP CAR TET | (2) | TEM | Class 1 | O157 | |||||
| MDR (3) | CAR NOR CHL | (1) | O157 | |||||||
| MDR (3) | AMP CAR NOR STX | (1) | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP CAR NET TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CEF TET | (2) | TEM (1), CTX (1) | Class 1 | ||||||
| MDR (3) | AMP CAR SXT TET | (1) | SHV | Class 1 | ||||||
| MDR (4) | AMP CEF SXT TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CEF TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP AMC CAR AMK GEN TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (4) | AMP AMK CAR GEN STX TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR OXA AMK GEN NET CEF CTX CIP NOR CHL TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (6) | AMP AMC CAR AMK GEN NET CEF CTX CIP NOR SXT TET | (1) | TEM+CTX+SHV | Class 1 | O157 | |||||
| XDR (8) | AMP AMC CAR AMK NET CEF CIP NOR CHL SXT NIT TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| XDR (8) | AMP AMC CAR OXA AMK GEN CEF CTX CIP NOR CHL SXT NIT TET | (1) | TEM+CTX+SHV | Class 1 | O157 | |||||
|
| ||||||||||
| (0) | 0 | (10) | ||||||||
| (1) | AMP | (3) | ||||||||
| (1) | CHL | (2) | ||||||||
| (1) | CAR | (2) | ||||||||
| (1) | AMP CAR | (3) | TEM (3) | |||||||
| (2) | CEF TET | (1) | ||||||||
| (1) | AMP AMK CAR | (1) | CTX | O157 | ||||||
| (2) | AMP AMK GEN | (1) | CTX | |||||||
| (2) | AMP CAR GEN | (1) | CTX | |||||||
| (2) | AMP CAR TET | (1) | TEM | Class 1 | O157 | |||||
| (2) | AMP CAR CHL | (1) | CTX | O157 | ||||||
| (2) | AMP CAR GEN NET | (1) | CTX | O157 | ||||||
| MDR (3) | AMP CAR CIP TET | (1) | SHV | Class 1 | O157 | |||||
| MDR (3) | AMP CAR CEF TET | (1) | SHV | Class 1 | O157 | |||||
| MDR (4) | CAR CHL STX TET | (1) | Class 1 | O157 | ||||||
| MDR (3) | AMP CAR CHL TET | (2) | TEM (2) | Class 1 | O157 | |||||
| MDR (4) | AMP CAR AMK CEF TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP CAR CIP STX TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP CAR AMK GEN TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP AMC CAR OXA CIP TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (4) | AMP CAR CHL STX TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (3) | AMP CAR GEN NET CEF | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP CAR AMK CTX TET | (1) | CTX | Class 1 | O157 | |||||
| MDR (3) | AMP AMC CAR AMK GEN TET | (1) | TEM | Class 1 | ||||||
| MDR (4) | AMP AMC AMK CEF CTX TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP AMC CAR CHL NIT TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR CEF NOR STX TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMP AMC CAR OXA CIP NOR CHL TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR AMK CEF CHL TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR AMK CEF NOR TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (4) | AMC AMK CAR CEF CTX CHL TET | (1) | TEM | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR GEN NET CEF STX TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR AMK CEF CTX NOR TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| MDR (5) | AMP AMC CAR OXA AMK GEN NET CEF NOR TET | (1) | TEM+CTX | Class 1 | O157 | |||||
| XDR (8) | AMP AMC CAR OXA GEN NET CEF CTX CIP CHL STX NIT TET | (1) | TEM+CTX+SHV | Class 1 | O157 | |||||
MDR; Multi Drug-Resistant, XDR; Extensively Drug-Resistant; AMP: Ampicillin, AMC: Amoxicillin, AMK: Amikacin, CAR: Carbenicillin, OXA: Oxacillin, GEN: Gentamicin, NET: Netilmicin, CEF: Cefalotin, NOR: Norfloxacin, CTX: Cefotaxime CIP: Ciprofloxacin, CHL: Chloramphenicol, STX: Trimethoprim-sulfamethoxazole, NIT: Nitrofurantoin TET: Tetracycline.